Several local companies are developing technologies that they hope could replace a painful poke with something that feels more like having Velcro against your skin for a few minutes.
An arson suspect was arrested after barricading himself in a Sacramento County home that caught fire during a standoff Friday ...
Kansas voters will get the chance to approve or deny a constitutional change that would cap property tax assessments in the ...
FDA approves suzetrigine for short-term pain relief Offers opioid-level pain relief without addiction risks First new painkiller mechanism approved in 20+ years ...
FDA Approves Symbravo for Acute Treatment of Migraine in Adults By Lori Solomon HealthDay Reporter WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved ...
Novo Nordisk (NYSE:NVO) just scored a game-changing FDA approval for Ozempic, expanding its use beyond diabetes to tackle chronic kidney disease and cardiovascular risks. The move solidifies ...
Secretary of State Marco Rubio has approved some waivers for emergency food aid and some salaries after President Donald Trump’s executive order to halt and reevaluate all foreign development ...
Novo Nordisk said the Food and Drug Administration approved the diabetes-drug Ozempic to be used to help kidney-disease patients. Ozempic, or semaglutide, can now be used to reduce the risk of ...
The new indications, approved Tuesday by the FDA, make Ozempic the most broadly indicated drug in its class, with the largest set of specific medical conditions that it may be prescribed to treat.
MANILA, Philippines — A bill to allow graduating junior high school students to pick alternative education pathways has been approved on third and final reading by the House of Representatives ...
Broccoli florets sold in Walmart stores across 20 states that were recalled over bacterial contamination fears have been given the U.S. Food and Drug Administration (FDA)'s highest risk level.
At the same point in his first term, 49% of voters approved of his job performance, and 41% disapproved, according to Morning Consult. NEW: One week into @realDonaldTrump's second term ...